Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GNW
GNW logo

GNW Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Genworth Financial Inc (GNW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.820
1 Day change
-0.34%
52 Week Range
9.280
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Genworth Financial Inc (GNW) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, has mixed financial performance, and shows no strong trading signals or trends to suggest immediate upside potential. Holding or exploring other opportunities may be more prudent.

Technical Analysis

The MACD is above 0 and positively contracting, indicating a mild bullish signal. RSI is neutral at 52.114, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in price movement. Key support is at 8.23, and resistance is at 8.832. Overall, the technical indicators do not suggest a strong trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market. However, implied volatility is high (52.06) with an IV percentile of 95.2, suggesting elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
11

Positive Catalysts

  • Analyst coverage re-initiated with an Outperform rating and a price target of $10.50, indicating potential upside. The life insurance sector has shown improved free cash flow conversion and reduced liability tail risk.

Neutral/Negative Catalysts

  • Net income dropped significantly by -300.00% YoY in the latest quarter, raising concerns about profitability. The stock is projected to decline in the next day (-1.03%), week (-2.67%), and month (-3.97%). No recent news or significant insider/hedge fund activity to drive the stock higher.

Financial Performance

In Q4 2025, revenue increased by 1.13% YoY to $1.797 billion, but net income dropped drastically by -300.00% YoY to $2 million. EPS remained flat at 0.01 YoY, and gross margin showed no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Keefe Bruyette re-initiated coverage with an Outperform rating and a $10.50 price target. Analysts highlight mixed fundamentals in the life insurance sector, with benefits from reduced liability risks and improved cash flow offset by rising competition and balance sheet complexity.

Wall Street analysts forecast GNW stock price to rise
1 Analyst Rating
Wall Street analysts forecast GNW stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.850
sliders
Low
10
Averages
10
High
10
Current: 8.850
sliders
Low
10
Averages
10
High
10
Keefe Bruyette
initiated
$10.50
AI Analysis
2026-03-26
Reason
Keefe Bruyette
Price Target
$10.50
AI Analysis
2026-03-26
initiated
Reason
Keefe Bruyette re-initiated coverage of Genworth with an Outperform rating and $10.50 price target. The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Keefe Bruyette
Keefe
Market Perform -> Outperform
upgrade
$9
2025-06-18
Reason
Keefe Bruyette
Keefe
Price Target
$9
2025-06-18
upgrade
Market Perform -> Outperform
Reason
Keefe Bruyette upgraded Genworth to Outperform from Market Perform with a price target of $9, up from $8.50. The company could potentially recover $500M, or $1.25 per share, related to a European payment protection business it previously sold to AXA, and a counter lawsuit between AXA and Santander, the analyst tells investors in a research note. The firm says a ruling is expected mid-to-late summer, and proceeds could total as much as 15%-20% of Genworth's market capitalization. In addition, Genworth currently trades at a 22% discount to its implied sum-of-the-parts with no lawsuit recovery, greater than the 15% average discount since mid-2023, notes Keefe.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GNW
Unlock Now

People Also Watch